Teva Pharmaceutical Industries LtdTEVA:TLV

23,480
90.00 / 0.38%
1.27m
31.47%
0.6113
Close in ILAToday's changeShares traded1 year changeBeta
Data delayed at least 20 minutes, as of May 28 2015 15:39 BST.

Summary

On Thursday, Teva Pharmaceutical Industries Ltd (TEVA:TLV) closed at 23,480, 12.19 % below its 52-week high of 26,740, set on Apr 13, 2015.

52-week range
Today
17,410
May 29 2014
26,740
Apr 13 2015
Open23,550
Day high23,650
Day low23,320
Bid23,480
Offer23,500
Previous close23,390
Average volume510.64k
Shares outstanding959.35m
Free float944.75m
P/E (TTM)18.76
Market cap223.89bn ILS
EPS (TTM)12.44 ILS
Annual div (IAD)430.33 ILA
Annual div yield (IAD)1.84%
Div ex-dateMay 19 2015
Div pay-dateJun 04 2015
Data delayed at least 20 minutes, as of May 28 2015 15:39 BST.

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
Teva Pharmaceutical Industries Ltd-2.37 %0.00%+5.96 %+31.47 %+12.08 %
TASE TA-100 IDX-1.92 %+0.84 %+10.92 %+15.30 %+41.67 %
IL/HEALTH CARE-2.43 %0.00%+5.62 %+23.94 %+10.78 %
IL/PHARMACEUTICALS-2.43 %0.00%+5.62 %+23.94 %+10.78 %
Data delayed at least 20 minutes, as of May 28 2015 15:39 BST.
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.